menu search

November 2023 letter to shareholders

VANCOUVER, Washington, Nov. 03, 2023 (GLOBE NEWSWIRE) — Dear Shareholders, We write to provide an update on CytoDyn Inc. (“CytoDyn” or “Compan...

November 3, 2023, 8:02 pm

Why is werewolf therapeutics (howl) stock up 20% today?

Werewolf Therapeutics (NASDAQ: HOWL ) stock is on the rise Friday after the company released preliminary data from the phase 1/1b clinical trial. This...

November 3, 2023, 10:26 am

Kalvista pharmaceuticals to present data at the 2023 annual scientific meeting of the american college of allergy, asthma & immunology

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...

November 2, 2023, 6:30 am

molecular partners to present initial data from ongoing phase 1/2a trial of mp0533 for patients with relapsed/refractory aml and aml/mds at the 65th ash annual meeting and exposition

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR ...

November 2, 2023, 2:00 am

molecular future (mof) showcasing remarkable journey

molecular Future (MOF), a leading digital asset investment service, invites the world to revisit its dy...

November 1, 2023, 6:20 pm

Why is mainz biomed (mynz) stock moving today?

Mainz Biomed (NASDAQ: MYNZ ) stock is on the move Wednesday after the molecular genetics cancer diagno...

November 1, 2023, 8:40 am

Hft molecule ai ea mt4 – free download

HFT molecule AI EA Review In the fast-paced world of Forex trading, having a cutting-edge tool at your ...

November 1, 2023, 8:00 am

Why is cardio diagnostics (cdio) stock up 45% today?

Shares of cardiovascular medicine specialist Cardio Diagnostics (NASDAQ: CDIO ) are skyrocketing on Tuesday following the announcement of a key deal. ...

October 31, 2023, 3:56 pm

Context therapeutics reveals ‘encouraging' preclinical data for ctim-76 tumor treatment

Context Therapeutics (NASDAQ:CNTX) Inc has announced what it called encouraging preclinical data regarding its preclinical asset, CTIM-76, a Claudin 6...

October 31, 2023, 10:12 am

Xilio to host virtual investor conference call and webcast on monday, november 6, 2023 to review progress across pipeline, including phase 1/2 clinical data for xtx202, a tumor-activated, engineered,

WALTHAM, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and devel...

October 31, 2023, 9:15 am

Fulcrum therapeutics to host third quarter 2023 financial results conference call and webcast on tuesday, november 7, 2023, at 8:00 a.m. et

CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutica...

October 31, 2023, 8:50 am

Dmtk shareholders: contact robbins llp for information regarding the class action against dermtech, inc.

SAN DIEGO, Oct. 30, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons and e...

October 30, 2023, 10:19 pm

molecular partners interim management statement q3 2023: continued validation seen across the …

Financial and Business Outlook For the full year 2023, at constant exchange rates, the Company expects total expenses of CHF 65-70 million, of which a...

October 26, 2023, 9:14 pm

Monte rosa therapeutics announces $25 million registered direct offering, priced at- the-market under nasdaq rules

BOSTON, Oct. 26, 2023 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel ...

October 26, 2023, 8:30 pm

Tradeweb markets inc. (tw) q3 2023 earnings call transcript

Tradeweb Markets Inc. (NASDAQ:TW ) Q3 2023 Results Conference Call October 26, 2023 9:30 AM ET Company Participants Ashley Serrao - Head-Treasury, FP&...

October 26, 2023, 2:30 pm

89bio's low price presents an opportunity

89bio, Inc. stock dropped along with other NASH players after Akero's efruxifermin failed a phase 2 trial. Despite the drop, 89bio remains attractive ...

October 26, 2023, 2:15 pm

Clarkson professors awarded $749,000 usda grant to develop technology to remove phosphate from agricultural fields and prevent nutrient pollution

Potsdam, NY, Oct. 25, 2023 (GLOBE NEWSWIRE) — Silvana Andreescu, Egon Matijevic Endowed Chair Professor of Chemistry and Bio...

October 25, 2023, 5:22 pm

Marketaxess holdings, inc. (mktx) q3 2023 earnings call transcript

MarketAxess Holdings, Inc. (NASDAQ:MKTX ) Q3 2023 Earnings Conference Call October 25, 2023 10:00 AM ET Company Participants Stephen Davidson - Head o...

October 25, 2023, 2:28 pm

Moderna and caris life sciences partner to develop mrna oncology therapeutics

Moderna Therapeutics Inc (NASDAQ:MRNA) has teamed up with Texas-headquartered private precision medicine and m...

October 24, 2023, 10:21 am


Search within

Pages Search Results: